Clinical Trials Logo
  1. Home
  2. Nash
  3. NCT03207425

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

NASH Clinical Trial

Official title:
A Phase 1, Open-Label, Parallel Group, Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of EDP 305 in Subjects With Varying Degrees of Hepatic Function

Clinical Trial Summary

This is a study to characterize the pharmacokinetics as well as safety and tolerability of a single oral dose of EDP-305 in subjects with mild and moderate hepatic impairment compared to matched healthy subjects.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03207425
Study type Interventional
Source Enanta Pharmaceuticals
Contact
Status Completed
Phase Phase 1
Start date June 14, 2017
Completion date September 19, 2017
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05479721 - LITMUS Imaging Study
Recruiting NCT06308757 - Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis N/A
Completed NCT02923154 - Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) Phase 2
Withdrawn NCT03980912 - Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy
Terminated NCT04565717 - A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH) Phase 1
Recruiting NCT04302051 - Assessment of Fatty Liver With Thermo-acoustic Device
Recruiting NCT05327127 - Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis Phase 2
Completed NCT06348706 - Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 Diabetes Phase 3
Recruiting NCT05935488 - Early Liver Disease Breath Detection
Active, not recruiting NCT06315361 - DIAbetes and NAFLD
Completed NCT03187496 - Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. Phase 1
Recruiting NCT04442334 - The European NAFLD Registry
Recruiting NCT06338969 - The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis N/A
Completed NCT05193916 - A Phase II Clinical Trial of Chiglitazar for NASH Phase 2
Active, not recruiting NCT05669677 - Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
Not yet recruiting NCT04783116 - Plant Stanols and Liver Inflammation in Overweight and Obese Children N/A
Recruiting NCT06193629 - A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar N/A
Completed NCT04006145 - A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH Phase 2
Recruiting NCT04232293 - Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus N/A
Recruiting NCT06410924 - A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH Phase 2